AU6536698A - Anti-sense oligonucleotide pharmacological agents - Google Patents
Anti-sense oligonucleotide pharmacological agentsInfo
- Publication number
- AU6536698A AU6536698A AU65366/98A AU6536698A AU6536698A AU 6536698 A AU6536698 A AU 6536698A AU 65366/98 A AU65366/98 A AU 65366/98A AU 6536698 A AU6536698 A AU 6536698A AU 6536698 A AU6536698 A AU 6536698A
- Authority
- AU
- Australia
- Prior art keywords
- pharmacological agents
- sense oligonucleotide
- oligonucleotide
- sense
- pharmacological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- 239000000074 antisense oligonucleotide Substances 0.000 title 1
- 238000012230 antisense oligonucleotides Methods 0.000 title 1
- 239000002831 pharmacologic agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
- C12N2310/3181—Peptide nucleic acid, PNA
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3879797P | 1997-02-24 | 1997-02-24 | |
| US60038797 | 1997-02-24 | ||
| PCT/US1998/003636 WO1998037240A1 (fr) | 1997-02-24 | 1998-02-24 | Agents pharmacologiques a base d'oligonucleotides antisens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6536698A true AU6536698A (en) | 1998-09-09 |
Family
ID=21901959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU65366/98A Abandoned AU6536698A (en) | 1997-02-24 | 1998-02-24 | Anti-sense oligonucleotide pharmacological agents |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1007735A1 (fr) |
| JP (1) | JP2001524942A (fr) |
| AU (1) | AU6536698A (fr) |
| WO (1) | WO1998037240A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1169480A4 (fr) | 1999-04-14 | 2005-02-02 | Musc Found For Res Dev | Agents toxiques et ribozymes specifiques de tissu et specifiques de pathogene |
| JP2005537028A (ja) | 2002-06-26 | 2005-12-08 | ザ ペン ステート リサーチ ファウンデーション | ヒト乳頭腫ウイルス感染症を治療する方法及び材料 |
| DE10332854A1 (de) | 2003-07-18 | 2005-02-17 | Universitätsklinikum der Charité der Humboldt-Universität zu Berlin | Verwendung des neu-identifizierten humanen Gens 7a5/Prognostin für Tumordiagnostik und Tumortherapie |
| EP1498133A1 (fr) | 2003-07-18 | 2005-01-19 | Aventis Pharma Deutschland GmbH | Utilisation d'inhibiteur de pak pour le traitement d'une maladie articulaire |
| TW201241179A (en) | 2010-12-17 | 2012-10-16 | Sanofi Sa | MiRNAs in joint disease |
| TW201239097A (en) | 2010-12-17 | 2012-10-01 | Sanofi Sa | MiRNAs in joint disease |
| TW201238974A (en) | 2010-12-17 | 2012-10-01 | Sanofi Sa | MiRNAs in joint disease |
| TW201238973A (en) | 2010-12-17 | 2012-10-01 | Sanofi Sa | MiRNAs in joint disease |
| EP2532755A1 (fr) | 2011-06-10 | 2012-12-12 | Sanofi-Aventis | Procédés et utilisations basés sur l'expression de Slfn2 et liés à l'identification et au profilage de composés pour une utilisation dans le traitement ou la prévention de la douleur |
| WO2012168453A1 (fr) | 2011-06-10 | 2012-12-13 | Sanofi | Méthodes et utilisations concernant le diagnostic ou le pronostic des états d'un tissu associés à la douleur ou des maladies associées à la douleur tels que la douleur |
| CA2925691A1 (fr) | 2013-10-01 | 2015-04-09 | Ruprecht-Karls-Univeristat Heidelberg | Traitement de l'insuffisance cardiaque a base de s100 |
| EP2857501A1 (fr) | 2013-10-03 | 2015-04-08 | ETH Zurich | Reprogrammation de cellules souches pluripotentes pour le contrôle amélioré de leurs voies de différentiation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
-
1998
- 1998-02-24 EP EP98911409A patent/EP1007735A1/fr not_active Withdrawn
- 1998-02-24 WO PCT/US1998/003636 patent/WO1998037240A1/fr not_active Ceased
- 1998-02-24 JP JP53699798A patent/JP2001524942A/ja not_active Ceased
- 1998-02-24 AU AU65366/98A patent/AU6536698A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998037240A1 (fr) | 1998-08-27 |
| JP2001524942A (ja) | 2001-12-04 |
| EP1007735A1 (fr) | 2000-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU9023798A (en) | Mdm2-specific antisense oligonucleotides | |
| EG21520A (en) | Dispenser | |
| EP0977701A4 (fr) | Distributeur | |
| GB9510718D0 (en) | Antisense oligonucleotides | |
| AU3811897A (en) | Antisense oligonucleotides as antibacterial agents | |
| AU135774S (en) | Dispenser | |
| IL132086A0 (en) | Pharmacological agents | |
| AU5259498A (en) | Antisense oligonucleotides | |
| GB9505438D0 (en) | Antisense oligonucleotides | |
| AU6536698A (en) | Anti-sense oligonucleotide pharmacological agents | |
| GB9711919D0 (en) | Oligonucleotide derivatives | |
| AU135821S (en) | Dispenser | |
| AU6186398A (en) | Process for selecting anti-sense oligonucleotides | |
| AUPO912997A0 (en) | Antiviral agents | |
| AUPO759797A0 (en) | Dispenser | |
| AU6709998A (en) | Toilet | |
| AU5678798A (en) | Antiviral agents | |
| AU5372998A (en) | Antisense oligonucleotides specific for cdk4 | |
| AU134289S (en) | Dispenser | |
| AU8333698A (en) | Dispenser | |
| AU6198098A (en) | Wipes | |
| GB2323587B (en) | Dispenser | |
| AU1396100A (en) | Oligonucleotide conjugation | |
| AU9468298A (en) | Event distributor | |
| HK1027097A (en) | Pharmacological agents |